Neonatal Respiratory Distress Syndrome

Slide 1 · Neonatal Respiratory

Distress Syndrome

Surfactant deficiency, hyaline membranes, and the consequences of premature lung development

Hyaline membrane disease

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain how surfactant deficiency produces progressive atelectasis and respiratory failure.

Recognize the characteristic gross and microscopic morphology of hyaline membrane disease.

Relate risk factors, clinical evolution, prevention, and treatment to the underlying mechanism.

Explain the pathogenesis of retinopathy of prematurity and bronchopulmonary dysplasia.

Slide 3 · Respiratory distress in newborns has several causes

Surfactant-deficient RDS

Most common cause described in the neonatal section

Also called hyaline membrane disease

Strongly linked to prematurity

Other causes listed

Excessive maternal sedation

Fetal head injury during delivery

Aspiration of blood or amniotic fluid

Intrauterine hypoxia from cord compression

Slide 4 · Hyaline membrane disease is a form of neonatal RDS

Pulmonary immaturity creates inadequate surfactant at the alveolar air–liquid interface.

Repeated alveolar collapse initiates epithelial and endothelial injury.

Protein-rich eosinophilic membranes form within peripheral airspaces.

The membrane is a consequence of injury—not the primary initiating defect.

Slide 5 · RDS risk increases steeply with prematurity

Reported incidence without preventive treatment

37 weeks

1%

34 weeks

10.5%

≤28 weeks

93%

Source: Robbins, 11th ed. • Not a contemporary population estimate

Textbook incidence values in infants without preventive treatment.

Gestational maturity is a major determinant of surfactant availability.

Slide 6 · Prematurity and growth restriction are not equivalent

Preterm infant

Born before full gestational maturation

Weight is often appropriate for gestational age

Lung immaturity underlies classic RDS

Growth-restricted infant

Small for gestational age due to impaired fetal growth

May be born at term

Intrauterine stress may accelerate surfactant maturation

Slide 7 · Clinical associations identify vulnerable neonates

Affected infants are almost always preterm and often appropriate in weight for their gestational age.

RDS is associated with male sex.

Infants of diabetic mothers have a higher risk.

Cesarean delivery, particularly before onset of labor, is another risk association.

Slide 8 · Surfactant acts at the alveolar air–liquid interface

Aerated lumen

Schematic: Surfactant film at air–liquid interface

A lipid–protein film lowers surface tension along the fluid-lined alveolar surface.

Lower surface tension reduces the pressure needed to keep alveoli open.

Slide 9 · Pulmonary surfactant is a lipid–protein complex

Lipid components

Predominantly dipalmitoyl phosphatidylcholine (lecithin)

Smaller amounts of phosphatidylglycerol

Surfactant proteins

Hydrophilic: SP-A and SP-D

Hydrophobic: SP-B and SP-C

Slide 10 · Phosphatidylcholine is the predominant surfactant lipid

Dipalmitoyl phosphatidylcholine is the dominant phospholipid.

Surfactant lipids act with hydrophobic proteins at the alveolar air–liquid boundary.

Surface-tension reduction is central to preventing alveolar collapse.

A compositional defect becomes a mechanical lung defect.

Slide 11 · SP-A and SP-D participate in innate host defense

SP-A

Hydrophilic surfactant-associated glycoprotein.

SP-D

Hydrophilic surfactant-associated glycoprotein.

Function

Both contribute to pulmonary host defense (innate immunity).

Slide 12 · SP-B and SP-C support low surface tension

SP-B

Hydrophobic surfactant-associated protein.

SP-C

Hydrophobic surfactant-associated protein.

Function

Cooperate with surfactant lipids to lower alveolar surface tension.

Slide 13 · Congenital protein deficiency illustrates surfactant necessity

Mutations involving

SFTPB or SFTPC

Congenital surfactant

Protein deficiency

Severe neonatal

Respiratory failure

This molecular example supports the essential mechanical role of surfactant proteins.

Slide 14 · Type II pneumocytes are the source of surfactant

Type II cell

Schematic: Epithelial source of surfactant

Type II alveolar epithelial cells synthesize and release surfactant.

Functional immaturity of this cell population limits surfactant availability after preterm birth.

Slide 15 · Surfactant production accelerates late in gestation

Before late gestation

Limited pulmonary maturation

After week 35

Surfactant production accelerates

At birth

Surfactant maintains aeration

The timetable helps explain the marked risk gradient by gestational age.

Slide 16 · Hormones and growth factors regulate surfactant synthesis

Glucocorticoids

Particularly important promoters of fetal lung maturation.

Other hormones

Insulin, prolactin, and thyroxine modulate synthesis.

Growth factors

TGF-β is among the regulators listed.

Slide 17 · Intrauterine stress may reduce RDS risk

Intrauterine stress

And some forms of FGR

Increased fetal

Corticosteroid release

Accelerated surfactant

Maturation

This is a relative protective association, not a claim that growth restriction is desirable.

Slide 18 · Maternal diabetes can delay functional maturation

Maternal diabetes

Compensatory fetal

Hyperinsulinemia

Insulin opposes

Steroid effect

Reduced surfactant

Maturation

The source presents this mechanism as one explanation for increased RDS risk.

Slide 19 · Labor is associated with increased surfactant synthesis

Labor before birth

Labor increases surfactant synthesis.

Favors functional adaptation at delivery.

Cesarean before labor

Lacks the labor-associated stimulus.

May increase RDS risk.

Slide 20 · Surfactant reduces the pressure needed for patency

Surfactant sufficient

Surfactant deficient

Patent airspace

Collapse

Schematic: Relative expansion only

Low surface tension supports expansion at physiologically attainable pressures.

High surface tension promotes collapse and increases respiratory work.

Slide 21 · The first breath requires a large inspiratory effort

Fluid-filled

Fetal lung

First breath: High

Inspiratory pressure

Alveolar expansion

And initial aeration

A normal surfactant film helps preserve this newly achieved aeration.

Slide 22 · After the first breath, surfactant preserves residual air

With adequate surfactant, lungs retain up to 40% of the residual air volume after the first breath (Robbins wording).

Retained air means subsequent breaths require substantially lower inspiratory pressures.

Failure to preserve this air creates repetitive reopening of collapsed units.

The decisive function is sustaining aeration from one breath to the next.

Slide 23 · Surfactant deficiency causes repeated collapse

Insufficient

Alveolar surfactant

Increased surface

Tension

End-expiratory

Alveolar collapse

Re-expansion required

With every breath

Slide 24 · An immature chest wall compounds respiratory effort

Stiff atelectatic lung

Low compliance: Difficult to inflate

Each breath requires high pressure

Soft thoracic wall

Pulled inward during diaphragmatic descent

Chest-wall retraction worsens work of breathing

Slide 25 · Atelectasis progresses to impaired ventilation

Progressive

Atelectasis

Reduced lung

Compliance

Hypoventilation and

Impaired perfusion

Respiratory

Compromise

Slide 26 · Gas exchange failure causes hypoxemia and acidosis

Poorly aerated alveoli

Carbon dioxide

Retention

Hypoxemia and

Respiratory acidosis

The source links these abnormalities to downstream pulmonary vascular and epithelial injury.

Slide 27 · Hypoxemia stimulates pulmonary vasoconstriction

Hypoxemia

Pulmonary

Vasoconstriction

Pulmonary

Hypoperfusion

Worsening tissue

Injury

Slide 28 · Endothelial and epithelial damage occur together

Endothelial injury

Increased vascular permeability

Plasma constituents leak toward alveolar airspaces

Epithelial injury

Injury and necrosis of lining cells

Necrotic cellular debris enters small airways

Slide 29 · Plasma leakage creates protein-rich alveolar exudate

Microvascular

Endothelial damage

Plasma proteins and

Fibrin enter airspaces

Proteinaceous material

Coats injured airways

Slide 30 · Cell necrosis contributes to membrane formation

Type II pneumocyte

Injury and necrosis

Cellular debris in distal

Airways and ducts

Debris admixed with

Fibrin-rich exudate

Slide 31 · Hyaline membranes are a secondary injury product

Airspace

Schematic: Membrane is not an H&E image

Eosinophilic material lines respiratory bronchioles, alveolar ducts, and alveoli.

Composition: Fibrin plus cellular debris, chiefly from necrotic type II pneumocytes.

Slide 32 · Hyaline membranes further impair gas exchange

Fibrin and

Necrotic cell debris

Hyaline membrane

Lining airspace

Additional barrier to

Gas exchange

Worsening hypoxemia

And CO₂ retention

Slide 33 · RDS reinforces itself through a vicious cycle

Surfactant deficiency

Atelectasis

Hypoxemia

Further impairment of

Surfactant synthesis

Amplifying

Feedback

The feedback loop helps explain clinical deterioration after an initially adequate transition.

Slide 34 · Normal aeration contrasts with RDS atelectasis

Surfactant sufficient

Surfactant deficient

Patent airspace

Collapse

Schematic: Relative expansion only

Normal surfactant preserves expanded alveolar units.

RDS lungs contain poorly inflated or collapsed distal airspaces.

Slide 35 · Gross lungs are solid and poorly aerated

Lungs are usually of normal size but have an airless, firm, liver-like character.

They are described as reddish purple.

This appearance reflects widespread lack of aerated lung tissue.

Grossly normal size does not imply normal alveolar aeration.

Slide 36 · Affected lungs may sink in water

Aerated lung

Entrapped air provides buoyancy.

Normal postnatal ventilation introduces air.

RDS lung

Relative lack of entrapped air

Tends to sink in water at autopsy

Slide 37 · Alveolar development and inflation are impaired

Immature, variably collapsed airspaces

Schematic—not histologic evidence

Alveoli are poorly developed and commonly collapsed.

Remaining immature airspaces may be lined by cuboidal epithelium.

Slide 38 · Necrotic debris is prominent in early fatal disease

Early in the disease, necrotic material is present in terminal bronchioles and alveolar ducts.

It later becomes incorporated into hyaline membranes.

This temporally links epithelial damage with the classical histologic lesion.

Early cell injury precedes organized membrane formation.

Slide 39 · The hyaline material lines peripheral airspaces

Airspace

Schematic: Membrane is not an H&E image

Respiratory bronchioles, alveolar ducts, and alveoli can be outlined by hyaline material.

The distribution is within distal airspaces, not simply inside blood vessels.

Slide 40 · Eosinophilic membranes contain fibrin and cell debris

Membrane material

Extravasated fibrin and plasma proteins

Necrotic cellular debris, predominantly type II cells

Associated tissue response

Collapsed or immature distal airspaces

Remarkably little neutrophilic inflammation

Slide 41 · Neutrophilic inflammation is notably sparse

Hyaline membranes are not accompanied by a marked neutrophilic infiltrate.

The lesion reflects epithelial–endothelial injury and plasma leakage, not a neutrophil-dominant process.

Interpret the membranes in the context of prematurity and respiratory failure.

Protein-rich membranes should not be mistaken for a purulent exudate.

Slide 42 · The characteristic lesions require postnatal breathing

These lesions are never seen in stillborn infants.

The pathogenesis depends on pulmonary transition, repeated atelectasis, and postnatal injury.

Timing is therefore an important clue to the lesion mechanism.

Hyaline membranes are a postnatal pathological response.

Slide 43 · Survivors beyond 48 hours show epithelial repair

Initial injury

Necrosis and membrane formation

After >48 hours

Alveolar epithelial proliferation

Recovery phase

Removal or incorporation of membranes

Slide 44 · Membranes may detach and undergo clearance

Epithelial growth

Beneath membrane

Membrane separation

Into airspace

Partial digestion or

Macrophage clearance

Slide 45 · Persistent membranes may become organized

Membrane persists

On alveolar surface

Fibroblast

Ingrowth

Incorporation into

Alveolar wall

Slide 46 · Histologic changes follow a recognizable sequence

Early

Distal collapse and cell necrosis

Established

Fibrin-rich hyaline membranes

Surviving infant

Epithelial regeneration or organization

Slide 47 · Initial stabilization may precede deterioration

Birth

Resuscitation may be necessary

First minutes

Rhythmic breathing/color may return

≈30 minutes onward

Breathing becomes difficult

Hours

Cyanosis may develop untreated

Slide 48 · Untreated disease produces progressive respiratory distress

Breathing becomes increasingly difficult soon after birth.

Cyanosis becomes apparent within hours in untreated infants.

Fine rales may be heard over both lung fields.

Increasing oxygen needs indicate impaired gas exchange.

Slide 49 · Chest radiography typically has a ground-glass pattern

The source describes uniform, minute reticulogranular densities.

The distributed opacification produces a ground-glass appearance.

Clinical presentation and gestational history provide the diagnostic context.

Radiography supports the clinicopathologic picture; It is not a substitute for it.

Slide 50 · Severe untreated RDS may resist high inspired oxygen

Widespread

Atelectasis

Membrane-related

Gas-exchange barrier

Persistent severe

Hypoxemia

Severe cases refractory even to high concentrations of administered oxygen.

Slide 51 · Mechanical failure and membrane injury are linked

Primary mechanical abnormality

Insufficient surfactant

Repeated airspace collapse

Decreased compliance

Secondary tissue injury

Hypoxemia and hypoperfusion

Epithelial and endothelial damage

Protein leakage and hyaline membranes

Slide 52 · Recovery commonly begins after the first several days

First hours

Potential respiratory deterioration

First 3–4 days

Critical period of support

Day 3–4

Recovery begins in uncomplicated cases

Survival through the early critical interval is associated with a good chance of recovery.

Slide 53 · Prognosis depends on maturity and timely therapy

Gestational maturity

Determines degree of pulmonary developmental immaturity.

Birth weight

Influences clinical course and prognosis.

Timely therapy

Prompt surfactant treatment alters clinical trajectory.

Slide 54 · Prevention aims to improve fetal lung maturity

At-risk preterm

Delivery

Delay delivery when

Possible

Or stimulate maturation

With antenatal steroids

These are prevention principles, not a management algorithm for an individual pregnancy.

Slide 55 · Amniotic-fluid phospholipids reflect fetal lung maturity

Pulmonary surfactant

Secretions

Entry into

Amniotic fluid

Phospholipid analysis

As maturity estimate

Biochemical assessment as a means of estimating alveolar surfactant status.

Slide 56 · Exogenous surfactant addresses the primary deficiency

Extreme

Prematurity

Low native

Surfactant

Exogenous surfactant

At birth

Improved pulmonary

Function

Prophylactic use for extremely preterm infants (<28 weeks); Contemporary use is protocol-dependent.

Slide 57 · Assisted ventilation supports gas exchange during recovery

Surfactant replacement

Targets the surface-tension defect.

Helps maintain airspace patency.

Assisted ventilation

Supports ventilation and oxygenation.

Newer techniques improve the clinical course.

Slide 58 · Therapy intervenes at multiple points in the mechanism

Antenatal steroids

(maturation)

Surfactant therapy

(alveolar interface)

Ventilatory support

(gas exchange)

Improved course /

Reduced mortality

Major improvements to combined prevention, replacement, and respiratory support.

Slide 59 · Major sequelae involve the retina and developing lung

Retinopathy of prematurity

A two-phase abnormal retinal angiogenic response.

Bronchopulmonary dysplasia

Impaired alveolar septation and abnormal vascular development.

Changing frequency

Both have become less frequent and less severe with improved care.

Slide 60 · Retinopathy: Hyperoxia suppresses VEGF

Hyperoxic treatment

Phase (phase I)

Reduced retinal

VEGF expression

Endothelial cell

Apoptosis

This is the first phase described model of retinopathy of prematurity.

Slide 61 · Retinopathy: Relative hypoxia drives neovascularization

Return toward

Relative hypoxia

VEGF

Rebound

Retinal vessel

Proliferation

The second phase produces characteristic pathological neovascularization.

Slide 62 · Two retinal phases explain opposite VEGF responses

Phase I: Hyperoxic

VEGF expression decreases

Endothelial apoptosis is promoted

Phase II: Relatively hypoxic

VEGF expression rebounds

Pathological retinal neovascularization occurs

Slide 63 · Bronchopulmonary dysplasia disrupts alveolar development

Schematic: Simplified airspaces; Not histology

Marked reduction in alveolar septation produces large, simplified airspaces.

Capillary configuration is also dysmorphic.

Slide 64 · BPD is viewed as arrested saccular-stage development

Premature saccular-stage

Lung

Impaired alveolar

Septation

Simplified airspaces and

Abnormal capillaries

A potentially reversible disturbance of alveolar development.

Slide 65 · Multiple factors contribute to bronchopulmonary dysplasia

Physical and oxygen stress

Hyperoxemia and hyperventilation may contribute.

Developmental susceptibility

Prematurity and vascular maldevelopment.

Inflammation

Inflammatory cytokines may arrest alveolar development.

Slide 66 · Inflammatory cytokines are increased in affected alveoli

TNF / IL-1β

Proinflammatory mediators noted in affected lungs.

IL-6 / IL-8

Also reported to be increased in alveoli.

Interpretation

Associations support a possible role in impaired septation.

Slide 67 · Prematurity carries complications beyond RDS

Patent ductus arteriosus

A common associated complication of premature birth.

Intraventricular hemorrhage

Another major prematurity-related risk.

Necrotizing enterocolitis

Intestinal complication often seen in preterm infants.

Slide 68 · Case: Severe distress in an extremely preterm infant

A neonate delivered at 27 weeks develops worsening breathing difficulty soon after birth.

Radiography shows fine diffuse reticulogranular opacities.

What is the primary physiological defect—and what tissue lesion results?

Mechanistic answer

Insufficient surfactant → repeated atelectasis → alveolar injury with fibrin-rich hyaline membranes.

Slide 69 · Case: Diabetic pregnancy and cesarean delivery

A preterm infant of a mother with diabetes is delivered by cesarean section before labor.

Respiratory distress develops shortly after an initially stable transition.

Identify two mechanisms linking the obstetric context to RDS risk.

Mechanistic answer

Fetal hyperinsulinemia may oppose corticosteroid-driven surfactant maturation; Absence of labor may reduce the usual surfactant-synthesis stimulus.

Slide 70 · Five mechanisms to retain

Initiation

Surfactant deficiency in an immature lung.

Mechanical failure

Increased tension, collapse, and low compliance.

Tissue lesion

Fibrin and epithelial debris form hyaline membranes.

Clinical expression

Early distress, hypoxemia, ground-glass imaging.

Complications

Retinopathy and disrupted alveolar development.

Slide 71 · Primary textbook reference

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026).

Chapter 10: Diseases of Infancy and Childhood.

Neonatal Respiratory Distress Syndrome, printed pp. 416–418.

Source figure descriptions: Fig. 10.6 (mechanism), Fig. 10.7 (histopathology).